US 12,410,210 B2
Neuroactive steroids and their methods of use
Maria Jesus Blanco-Pillado, Arlington, MA (US); Francesco G. Salituro, Marlborough, MA (US); and Marshall Lee Morningstar, Framingham, MA (US)
Assigned to Sage Therapeutics, Inc., Cambridge, MA (US)
Filed by SAGE THERAPEUTICS, INC., Cambridge, MA (US)
Filed on Mar. 26, 2024, as Appl. No. 18/616,995.
Application 18/616,995 is a continuation of application No. 18/334,124, filed on Jun. 13, 2023, granted, now 11,970,514.
Application 18/334,124 is a continuation of application No. 17/311,056, abandoned, previously published as PCT/US2019/064692, filed on Dec. 5, 2019.
Claims priority of provisional application 62/775,470, filed on Dec. 5, 2018.
Prior Publication US 2024/0343756 A1, Oct. 17, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. C07J 43/00 (2006.01); C07J 41/00 (2006.01)
CPC C07J 43/003 (2013.01) [C07J 41/0044 (2013.01); C07J 41/0094 (2013.01)] 23 Claims
 
1. A compound selected from
 
Exa- Structure
mple
 
305
 

OG Complex Work Unit Chemistry
 
306
 

OG Complex Work Unit Chemistry
 
317
 

OG Complex Work Unit Chemistry
 
318
 

OG Complex Work Unit Chemistry
 
325
 

OG Complex Work Unit Chemistry
 
326
 

OG Complex Work Unit Chemistry
 
 51
 

OG Complex Work Unit Chemistry
 
 52
 

OG Complex Work Unit Chemistry
 
355
 

OG Complex Work Unit Chemistry
 
 
and
 
356
 

OG Complex Work Unit Chemistry